IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $307,450 | +4.6% | 6,778 | -5.4% | 0.01% | 0.0% |
| Q2 2023 | $294,062 | +40.3% | 7,167 | +22.2% | 0.01% | +28.6% |
| Q1 2023 | $209,651 | -9.9% | 5,866 | -4.8% | 0.01% | -30.0% |
| Q4 2022 | $232,625 | +1.1% | 6,159 | +18.2% | 0.01% | 0.0% |
| Q3 2022 | $230,000 | +2.2% | 5,209 | -14.4% | 0.01% | 0.0% |
| Q2 2022 | $225,000 | +8.7% | 6,083 | +8.7% | 0.01% | 0.0% |
| Q1 2022 | $207,000 | -54.4% | 5,596 | -58.7% | 0.01% | -75.6% |
| Q3 2021 | $454,000 | – | 13,544 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 9,930,245 | $396,117,000 | 3.87% |
| Sicart Associates LLC | 368,409 | $14,696,000 | 3.50% |
| Camber Capital Management LP | 2,000,000 | $79,780,000 | 2.69% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 181,781 | $7,251,000 | 1.91% |
| SECTOR GAMMA AS | 263,488 | $10,511,000 | 1.86% |
| Parkman Healthcare Partners LLC | 136,380 | $5,440,000 | 1.19% |
| Eversept Partners, LP | 442,000 | $17,631,380 | 1.18% |
| Affinity Asset Advisors, LLC | 75,000 | $2,992,000 | 1.07% |
| TANAKA CAPITAL MANAGEMENT INC | 16,661 | $665,000 | 0.90% |
| Sonora Investment Management, LLC | 168,665 | $6,728,000 | 0.88% |